Berjame, Leopoldo D.

HRN: 21-70-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2023
CEFUROXIME 1.5GM (VIAL)
08/23/2023
08/30/2023
IV
1.5 Grams
Q8hrs
Inguinal Hernia, T/c Incarcerated
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: